Background Although incidence and mortality of lung cancer have been decreasing, health
disparities persist among historically marginalized Black, Hispanic, and Asian populations. A …

Aim: To provide an assessment of published literature on the demographic representation in
Phase I trials of biopharmaceutical oncology agents. Materials & methods: We conducted a …

Socioeconomic and racial disparities exist in access to care among patients with non-small
cell lung cancer (NSCLC) in the United States. Immunotherapy is a widely established …

Importance Declining treatment negatively affects health outcomes among patients with
cancer. Limited research has investigated national trends of and factors associated with …

Abstract Treatment of advanced non-small cell lung cancer (NSCLC) has markedly changed
in the past decade with the integration of biomarker testing, targeted therapies …

Purpose Implementation of nurse navigators during cancer screening to the first treatment
visit may facilitate early diagnosis and treatment. This study aims to demonstrate the …

Introduction Recent trials have reported promising results with the addition of
immunotherapy to chemotherapy for patients with locally advanced NSCLC, but in practice …

This article reviews the available literature on racial, sex, sexual identity, age, disability,
socioeconomic, and geographic disparities in lung cancer diagnosis, treatment, and …

PURPOSE: Social determinants of health have been linked to treatment-related disparities
in breast cancer. We analyzed data from a large national registry to explore factors related to …

Background: Race, gender, insurance status, and income play important roles in predicting
health care outcomes. However, the impact of these factors has yet to be fully elucidated in …